Drug class
Recombinant human bone morphogenetic protein 2 (rhBMP-2); osteoinductive biologic
Mechanism of action
Binds BMP receptors on mesenchymal progenitor cells and activates SMAD-dependent and related signalling pathways, promoting osteoblast differentiation and new bone formation.
General use cases
- Used in selected orthopaedic bone-regeneration indications to support bone formation, such as specific nonunion or spinal-fusion procedures, where the particular rhBMP-2 device/medicinal product is authorised; formulation, carrier and anatomical site determine the indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
